Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$951M |
| 2 |
Advanced Micro Devices
AMD
|
+$589M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$418M |
| 4 |
Lam Research
LRCX
|
+$412M |
| 5 |
Microsoft
MSFT
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$585M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$111M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$87.8M |
| 5 |
TSMC
TSM
|
+$70.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.05% |
| 2 | Financials | 11.79% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Vishay Intertechnology
VSH
$5.96B
| $76.6M | 0.05% |
3,812,963
-75,862
| -2% | -$1.64M |
|
|
PC
177
DELISTED
PANASONIC CORP ADR (REP 1 SHR COM STK) (JP)
PC
| $75.7M | 0.05% |
6,075,856
-1,611,463
| -21% | -$20.1M |
|
178
Lazard
LAZ
$4.21B
| $75.3M | 0.05% |
1,644,588
+368,169
| +29% | +$17.2M |
|
|
MDRX
179
DELISTED
Veradigm Inc. Common Stock
MDRX
| $74.9M | 0.05% |
5,605,226
-86,688
| -2% | -$1.4M |
|
180
Invesco NASDAQ Internet ETF
PNQI
$539M
| $74.3M | 0.05% |
1,556,410
+107,855
| +7% | +$5.43M |
|
181
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
| $73.2M | 0.05% |
574,801
+35,411
| +7% | +$4.68M |
|
182
WIX.com
WIX
$2.38B
| $72.4M | 0.05% |
369,414
+101,580
| +38% | +$25.2M |
|
183
Lumentum
LITE
$66.1B
| $71.7M | 0.04% |
858,688
+11,457
| +1% | +$961K |
|
184
Chemed
CHE
$7.07B
| $71.1M | 0.04% |
152,936
-3,357
| -2% | -$1.58M |
|
185
Lennar Class A
LEN
$20.5B
| $70.3M | 0.04% |
775,435
+5,303
| +0.7% | +$525K |
|
|
PDCE
186
DELISTED
PDC Energy, Inc.
PDCE
| $69.6M | 0.04% |
1,468,184
-24,401
| -2% | -$1.02M |
|
187
Artisan Partners
APAM
$2.99B
| $68.3M | 0.04% |
1,395,947
-40,227
| -3% | -$2.03M |
|
|
BECN
188
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $65.8M | 0.04% |
1,376,928
-34,395
| -2% | -$1.78M |
|
|
KSU
189
DELISTED
Kansas City Southern
KSU
| $64.7M | 0.04% |
239,094
-2,216
| -0.9% | -$617K |
|
|
DVAX
190
DELISTED
Dynavax Technologies
DVAX
| $63.9M | 0.04% |
3,323,777
+1,060,224
| +47% | +$14.1M |
|
191
HUB Group
HUBG
$2.83B
| $63.4M | 0.04% |
1,844,748
-40,968
| -2% | -$1.38M |
|
192
Bank of America
BAC
$437B
| $63.1M | 0.04% |
1,485,943
+3,579
| +0.2% | +$144K |
|
193
Medpace
MEDP
$16B
| $62.1M | 0.04% |
328,306
+35,282
| +12% | +$6.44M |
|
194
Polaris
PII
$4.02B
| $62M | 0.04% |
518,524
-14,711
| -3% | -$1.87M |
|
|
VRNT
195
DELISTED
Verint Systems
VRNT
| $58.5M | 0.04% |
1,307,008
+14,709
| +1% | +$640K |
|
196
First American
FAF
$7.7B
| $56.9M | 0.04% |
848,219
-16,112
| -2% | -$1.08M |
|
197
Range Resources
RRC
$9.43B
| $56.6M | 0.04% |
2,502,796
-30,754
| -1% | -$499K |
|
198
iShares MSCI Japan ETF
EWJ
$22.4B
| $56.6M | 0.04% |
805,105
+20,146
| +3% | +$1.4M |
|
199
Fair Isaac
FICO
$22.6B
| $53.3M | 0.03% |
133,991
+8,045
| +6% | +$3.83M |
|
200
Deere & Co
DE
$163B
| $53.2M | 0.03% |
158,829
+37,264
| +31% | +$13.4M |
|
Similar funds
Ken Fisher's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Fisher held 1,103 positions worth $161B, up 1.1% from $159B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q3 2021 filing shows 93 new, 444 increased, 375 reduced and 75 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M. The largest sale was Visa, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M.
- Ken Fisher added most to Meta Platforms (Facebook) in Q3 2021, an estimated $951M increase.
- Ken Fisher's biggest Q3 2021 reduction was Visa, cutting an estimated $1.24B.
- Ken Fisher fully exited Stamps.com, Inc. in Q3 2021, selling an estimated $111M.
- Ken Fisher's ten largest holdings make up 31% of its $161B portfolio in Q3 2021.
- Ken Fisher opened 93 new positions and closed 75 in Q3 2021.
- Ken Fisher's portfolio value rose 1.1% quarter-over-quarter to $161B.
Based on Fisher Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.